CareDx, Inc. (CDNA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 50M 100M 150M Q3 '21: 75.6M Q4 '21: 79.2M Q1 '22: 79.4M Q2 '22: 80.6M Q3 '22: 79.4M Q4 '22: 82.4M Q1 '23: 77.3M Q2 '23: 70.3M Q3 '23: 67.2M Q4 '23: 65.6M Q1 '24: 72M Q2 '24: 92.3M Q3 '24: 82.9M Q4 '24: 86.6M Q1 '25: 84.7M Q2 '25: 86.7M Q3 '25: 100.1M Q4 '25: 108.4M Q1 '26: 117.7M Q2 '26: 131.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 10M 20M 30M Q1 '18: 7.7M Q2 '18: 10.6M Q3 '18: 12.3M Q4 '18: 13M Q1 '19: 16.2M Q2 '19: 19.9M Q3 '19: 22.3M Q4 '19: 23.1M Q1 '20: 26M Q2 '20: 26.8M Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q2 '21: -4.7M Q3 '21: -8.7M Q4 '21: -15.4M Q1 '22: -19.1M Q2 '22: -21.7M Q3 '22: -17.3M Q4 '22: -19.1M Q1 '23: -24.3M Q2 '23: -27.6M Q3 '23: -28.8M Q4 '23: -122.6M Q1 '24: -22.6M Q2 '24: -7.3M Q3 '24: -13.7M Q1 '25: -13.4M Q2 '25: -11.1M Q3 '25: -246K Q4 '25: -6M Q1 '26: 1.2M Q2 '26: 113.2M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '21: -11.9M Q4 '21: -16.2M Q1 '22: -19.6M Q2 '22: -21.7M Q3 '22: -16.9M Q4 '22: -18.3M Q1 '23: -23.7M Q2 '23: -25M Q3 '23: -23.5M Q4 '23: -118.1M Q1 '24: -19.9M Q2 '24: -4.6M Q3 '24: -10.6M Q4 '24: 87.7M Q1 '25: -10.4M Q2 '25: -8.6M Q3 '25: 1.7M Q4 '25: -4.1M Q1 '26: 2.8M Q2 '26: 110.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 6M 12M 18M Q1 '18: 6.4M Q2 '18: 7.2M Q3 '18: 8.9M Q4 '18: 10.5M Q1 '19: 9.7M Q2 '19: 11.5M Q3 '19: 11.5M Q4 '19: 12.7M Q1 '20: 12.4M Q2 '20: 15M Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20

Operating Cash Flow Quarterly

-30M -15M 0 15M 30M 45M Q3 '21: 382K Q4 '21: 4.2M Q1 '22: -21.5M Q2 '22: -3.9M Q3 '22: -7.1M Q4 '22: 7.2M Q1 '23: 671K Q2 '23: -499K Q3 '23: -10.2M Q4 '23: -8.4M Q1 '24: -15.3M Q2 '24: 18.9M Q3 '24: 12.5M Q4 '24: 21.9M Q1 '25: -26.6M Q2 '25: 9.9M Q3 '25: 37.4M Q4 '25: 21.4M Q1 '26: 4.3M Q2 '26: 30.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '17: -3.2M Q3 '17: -2.2M Q4 '17: -2.2M Q1 '18: -4.6M Q2 '18: -2.3M Q3 '18: -215K Q4 '18: 1M Q1 '19: -6.4M Q2 '19: 3.6M Q3 '19: 196K Q1 '20: -4.8M Q2 '20: 22.4M Q3 '20: 2M Q1 '21: -34.9M Q2 '21: 7M Q3 '21: -3.2M Q1 '25: -28.2M Q2 '25: 8.9M Q1 '26: 514K Q2 '26: 28.7M Q3 '17 Q2 '18 Q1 '19 Q1 '20 Q1 '21 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 42.8M Q2 '20: 44.7M Q3 '20: 49M Q1 '21: 51.2M Q2 '21: 52.2M Q3 '21: 52.7M Q1 '22: 53M Q2 '22: 53.2M Q3 '22: 53.5M Q1 '23: 53.6M Q2 '23: 53.8M Q3 '23: 54.2M Q1 '24: 51.7M Q2 '24: 52.2M Q3 '24: 52.9M Q1 '25: 55.3M Q2 '25: 54.3M Q3 '25: 53.7M Q1 '26: 53.1M Q2 '26: 53.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -0.35 Q4 '21: -0.59 Q1 '22: -0.95 Q2 '22: -1.32 Q3 '22: -1.41 Q4 '22: -1.45 Q1 '23: -1.52 Q2 '23: -1.57 Q3 '23: -1.68 Q4 '23: -3.53 Q1 '24: -3.47 Q2 '24: -3.10 Q3 '24: -2.87 Q4 '24: 0.93 Q1 '25: 1.12 Q2 '25: 1.05 Q3 '25: 1.28 Q4 '25: -0.40 Q1 '26: -0.16 Q2 '26: 2.07 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.